Video

Dr. Smith on Unmet Clinical Needs in Indolent Lymphomas

Sonali M. Smith, MD, discusses unmet clinical needs in indolent lymphomas.

Sonali M. Smith, MD, Elwood V. Jensen Professor in Medicine, interim chief, Section of Hematology/Oncology, director, Lymphoma Program, University of Chicago Medicine, discusses unmet clinical needs in indolent lymphomas.

Prognostication at diagnosis is an area that needs to be better fleshed out, explains Smith.

Although prognostic indices such as the Follicular Lymphoma International Prognostic Index (FLIPI), the M7-FLIPI, and the FLIPI-2 are helpful for certain groups of patients, they have not been validated and are not applicable to individual patients, says Smith.

Additionally, establishing time-limited therapies that are well tolerated is critical to move the field forward, concludes Smith.

Related Videos
Consuelo Bertossi, MD
Michael R. Grunwald, MD, FACP
Sundar Jagannath, MBBS
Kevin Kalinsky, MD, MS,
Aaron Gerds, MD
Paolo Tarantino, MD
Chinmay Jani, MD, clinical fellow, Hematology & Oncology, Sylvester Comprehensive Cancer Center at the University of Miami/Jackson Memorial Hospital
Shella Saint Fleur-Lominy, MD, PhD
Benjamin Levy, MD
Nader Sanai, MD, chief, Neurosurgical Oncology, director, Ivy Brain Tumor Center, Barrow Neurological Institute